This trial is evaluating whether Decision support tool will improve 1 primary outcome and 1 secondary outcome in patients with Pregnant State. Measurement will happen over the course of up to 8 months following implementation of the intervention..
This trial requires 460 total participants across 2 different treatment groups
This trial involves 2 different treatments. Decision Support Tool is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
These treatments have varying safety as they affect the pregnant mother and potentially the unborn child, but most offer relief from symptoms of the disease.\n
Many of the non-specific signs and symptoms that occur during pregnancy are not considered to be specific to pregnancy. These include nausea and vomiting, premenstrual syndrome, uterine fibroids, preoccupation with childbirth, postnatal depression, vaginal discharge, and anxiety and irritability. A thorough history and examination is necessary. A comprehensive blood test may be useful to exclude complications of pregnancy.
The current study showed that the disease in pregnant women could only be cured after the removal of the fetus and delivery of the newborn.
Factors which impact on the risk of pregnancy and other factors such as pre-pregnancy smoking cessation might influence the chances of a developing pregnancy. Pregnancy itself may make an individual at risk of developing a condition such as preeclampsia.\n
Despite advances in obstetric care, still births in U.S. obstetrics and gynecology practice are frequent. A significant proportion of women deliver prematurely. Pregnant women are more likely to deliver by cesarean section than nonpregnant women. Furthermore, women under 50 years of age are likely to be treated with a cesarean delivery, even if they are uncomplicated.
It is necessary for clinical study coordinators to learn from the experiences of the nurses. Thus, by introducing the decision support tool, the nurses should be able to manage daily affairs with high levels of quality. The decision support tool is crucial to a research-oriented clinical trial being well operated.
In the present study, the CDSS software can be used as a tool for optimizing the treatment decisions and thereby reducing the need for repeated unnecessary diagnostic testing for women with suspected PTD.
Results from a recent paper, DSWT did not demonstrate superiority compared to a placebo when used to determine best treatment option in decision aid counseling of pregnant women with an asymptomatic pregnancy >35 weeks.
If you are planning to start a family or are already pregnant[and want to know about the different birth weight ranges for infants in the US], the average age people get pregnant states that 21.2 years. Additionally, the number of women who got pregnant by those 20.1 years of age doubled. These numbers will most likely be slightly more than what the average person's age in the US is. For more complete statistics see: https://www.cdc.gov/pregnancy-fact-files/faq/faq-pregnant-woman.htm.
Patients frequently encounter decisional aids during medical care. However, most people who need them ignore or disregard them. This might reflect either that decisional aids are not helpful or that the help they provide is not always clear, concise, or effective. Clinicians might want to educate themselves about the tools they can help patients use, and about the effectiveness or drawbacks of each choice. As well as providing advice about the patient's preferences, clinicians can role-play the patient while discussing the decision aid and helping the patient choose the most effective option for him or her.